NEW YORK--(BUSINESS WIRE)--Synchron, a brain computer interface (BCI) company, today announced the results from a study in which four people with ALS received an implant of Synchron’s Stentrode™ ...

Neuralink, Synchron, and Neuracle are expanding clinical trials and trying to zero in on an actual product. Tech companies are always trying out new ways for people to interact with computers—consider ...

Please provide your email address to receive an email when new articles are posted on . The Stentrode brain-computer interface offers a non-invasive, nonsurgical solution for paralysis. Additional ...

A renowned company best known for its brain implants has made headway towards more applications for its latest design, with Synchron announcing its milestones for the Stentrode device. The company ...

Synchron, a New York, NY-based manufacturer of non-surgical brain-computer interface technology, said it has raised a $200 million series D round. The funds are expected to accelerate ...